- Anaesthesia and Critical Care
- Ear, Nose and Throat
- Infectious Diseases
- Mental Health
- Metabolic and Endocrine
- Musculoskeletal Health
- Neuroprogressive and Dementia
- Oral and Dental
- Primary Care
- Regenerative Medicine
- Reproductive Health and Childbirth
- Trauma and Emergencies
For specific Coronavirus (COVID-19) research and guidance visit the Coronavirus information hub.
Our role is to support the delivery of high quality clinical research in Haematology Disorders and manage participant recruitment to time and target, both for studies which are led from Scotland, and studies led from other nations which Scottish sites are participating in. We aim to widen the participation of NHS Scotland Boards in Haematology studies on the NIHR CRN Portfolio, thereby increasing access for Scottish patients to Haematology studies.
We provide support in the following areas
- Managing the study portfolio record
- Monitoring the attainment of recruitment targets
- Providing advice on study design and feasibility
- Troubleshooting issues with poor recruitment
- Identifying potential sites for studies
- Facilitating access to resource to support research, for example through Clinical Research Facility (CRF) Research Nurses
- Facilitating research links and networking.
At the moment we support approximately 7 Haematology studies.
Non Malignant Haematology (NMH) Studies
The NMH Specialty Group’s portfolio includes:
- Bleeding disorders
There is overlap between the NMH Specialty Group and many other Specialty Groups and NIHR Topic Specific Research Networks. In general, the NMH Specialty Group will take the lead on research studies which are led by haematologists. Research studies of haematological cancers fall outside the remit of the NMH speciality group.
Patient, carer and public information
Specialty Lead: Vacant
Performance Manager: Graeme Piper